Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background & Aims</h3>Nearly all studies of gastric adenocarcinoma in the United States have relied on national cancer databases, which do not include data on Helicobacter pylori infection, the most well-known risk factor for gastric cancer. We collected data from a large cohort of patients in the United States to calculate the incidence of and risk factors for non-proximal gastric adenocarcinomas after detection of H pylori. Secondary aims included identifying how treatment and eradication affect cancer risk.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3>We performed a retrospective cohort study, collecting data from the Veterans Health Administration on 371,813 patients (median age, 62 years; 92.3% male) who received a diagnosis of H pylori infection from January 1, 1994 through December 31, 2018. The primary outcome was a diagnosis of distal gastric adenocarcinoma 30 days or more after detection of H pylori infection. We performed time to event with competing risk analysis (death before cancer a competing risk).<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3>The cumulative incidence of cancer at 5, 10, and 20 years after detection of H pylori infection was 0.37%, 0.5%, and 0.65%, respectively. Factors associated with cancer included older age at time of detection of H pylori infection (sub-hazard ratio [SHR], 1.13; 95% CI, 1.11–1.15; P<.001), black/African American race (SHR, 2.00; 95% CI, 1.80–2.22), Asian race (SHR, 2.52; 95% CI, 1.64–3.89) (P<.001 for race), Hispanic or Latino ethnicity (SHR, 1.59; 95% CI, 1.34–1.87; P<.001), or history of smoking (SHR, 1.38; 95% CI, 1.25–1.52; P<.001). Women had decreased risk of gastric adenocarcinoma compared with men (SHR, 0.52; 95% CI, 0.40–0.68; P<.001); patients whose H pylori infection was detected based on serum antibody positivity also had a reduced risk of cancer (SHR 0.74; 95% CI, 0.54-1.04; P=0.04). Patients who received treatment for their H pylori infection still had an increased risk of gastric cancer (SHR, 1.16; 95% CI, 0.74–1.83; P=.51), but confirmed H pylori eradication after treatment reduced risk of gastric cancer (SHR, 0.24; 95% CI, 0.15–0.41; P<.001).<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3>In a study of 371,813 veterans with a diagnosis of H pylori infection, we found significantly higher risks of gastric cancer in racial and ethnic minorities and smokers. Treatment of H pylori infection only decreased risk if eradication was successful. Studies are needed on the effects of screening high-risk persons and to identify quality measures for diagnosis, resistance patterns, and treatment efficacy.

Prevalence of the cagA Virulence Factor Varies by Race among H. pylori-infected Patients Undergoing Upper Endoscopy

Country-Specific Constancy by Age in Caga(+) Proportion of Helicobacter Pylori Infections

Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in a region at high risk of gastric cancer

Dominant Caga/vaca Genotypes and Coinfection Frequency of H. Pylori in Peptic Ulcer or Chronic Gastritis Patients in Zhejiang Province and Correlations among Different Genotypes, Coinfection and Severity of the Diseases.

Differential Helicobacter pylori Plasticity in the Gastric Niche of Subjects at Increased Gastric Cancer Risk

The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans

[Investigation on Caga/vaca Dominant Genotypes and the Coinfection of Helicobacter Pylori Isolates from Patients in Zhejiang].

Equally High Prevalences Of Infection With Caga-Positive Helicobacter Pylori In Chinese Patients With Peptic Ulcer Disease And Those With Chronic Gastritis-Associated Dyspepsia

Prevalence and virulence factors of Helicobacter pylori isolated from oral cavity of non-disease, gastritis, and gastric cancer patients

Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population

Helicobacter pylori burden in the United States according to individual demographics and geography: a nationwide analysis of the Veterans Healthcare System

[Effect of Helicobacter Pylori-Encoded CagA on Biological Behavior of Gastric Adenocarcinoma Cells in Vitro].

Helicobacter Pylori Prevalence and CagA Status among Children in Two Counties of China with High and Low Risks of Gastric Cancer.

Relationship between Helicobacter pylori virulence genes and gastroduodenal disease

The prevalence and risk factors of Helicobacter pylori infection and cagA virulence gene carriage in adults in the Navajo Nation

The Diversity of Vaca and Caga Genes of Helicobacter Pylori in East Asia.

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

CagA toxin and risk of Helicobacter pylori-infected gastric phenotype: A meta-analysis of observational studies

Detection of Helicobacter pylori and its virulence genes (cagA, dupA, and vacA) among patients with gastroduodenal diseases in Chris Hani Baragwanath Academic Hospital, South Africa

Clinical relevance of the cagA, tnpA and tnpB genes in Helicobacter pylori

Helicobacter pylori CagA protein variation associated with gastric cancer in Asia